Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 17, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 19, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001796068-26-000002
Filed / recorded
Feb 19, 2026, 1:02 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Penumbra Inc
Issuer CIK
1321732
Ticker
PEN
Reporting person
Lambert Shiu
Relationship
Officer
Officer title
Chief Accounting Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 17, 2026
Transaction code
A
Shares / units
2,300
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
39,473
Ownership form
Direct
Amendment
No
Footnotes from the filing
On February 17, 2026, the Reporting Person was granted 2,300 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.